Liver transplant study for people with HIV
Part of Immune system & allergy, Infections clinical trials.
This study tests whether it's safe and effective for people with HIV to receive a liver transplant from a donor who also has HIV. It aims to expand access to transplants for people with HIV.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have HIV and are on the transplant waiting list for a liver (or a liver and kidney together).
- Your most recent HIV viral load is 50 copies/mL or lower (some variation is allowed).
- You are able to take antiretroviral therapy after the transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether hearts from donors who had HIV can be safely transplanted into people with HIV who need a heart transplant. It may offer a new option for those on the waiting list.
This study tests a new way to preserve donated livers using a special machine that keeps the liver cool and pumps fluid through it before transplantation. This may help the liver stay in better condition for the recipient, which could improve transplant success.
This study tests whether giving people with HIV a liver from an HIV-positive donor is safe and works well. It looks at infections, cancer risks, and long-term health after transplant.
This trial studies whether it’s safe and effective for HIV-positive people to receive organ transplants from HIV-positive donors. It focuses on matching HIV treatment before and after transplant and checking for major complications.
This study tests whether kidney transplants from donors with HIV are safe and effective for people with HIV who need a new kidney. It looks at long-term outcomes like rejection and survival.
This trial uses a special blood-filtering procedure (leukapheresis) along with blood tests to better understand how HIV affects the body. It may help researchers learn more about HIV “pathogenesis,” which means what drives disease in different people.
Hear when a new Liver Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.